# A Study of Resveratrol as Treatment for Friedreich Ataxia

> **NCT01339884** · PHASE1,PHASE2 · COMPLETED · sponsor: **Murdoch Childrens Research Institute** · enrollment: 27 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Resveratrol

## Key facts

- **NCT ID:** NCT01339884
- **Lead sponsor:** Murdoch Childrens Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01339884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01339884, "A Study of Resveratrol as Treatment for Friedreich Ataxia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01339884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*